The estimated Net Worth of Mark B Logan is at least 9.14 千$ dollars as of 8 November 2012. Mark Logan owns over 3,600 units of VIVUS stock worth over 9,143$ and over the last 21 years Mark sold VVUS stock worth over 0$.
Mark has made over 4 trades of the VIVUS stock since 2012, according to the Form 4 filled with the SEC. Most recently Mark bought 3,600 units of VVUS stock worth 18,792$ on 8 November 2012.
The largest trade Mark's ever made was exercising 49,816 units of VIVUS stock on 14 August 2012 worth over 280,962$. On average, Mark trades about 2,378 units every 7 days since 2004. As of 8 November 2012 Mark still owns at least 19,600 units of VIVUS stock.
You can see the complete history of Mark Logan stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at VIVUS have traded over 6,261,269$ worth of VIVUS stock and bought 5,180,746 units worth 13,074,554$ . The most active insiders traders include Tide Capital, Llc North Tid...、Alexander J Denner、Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of 35,394$. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth 53,350$.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: